Cancer Treatment Centers of America (CTCA) Atlanta has achieved three-year re-accreditation as a Comprehensive Community Cancer Program from the Commission on Cancer (CoC), a program of the American College of Surgeons.

Accreditation from the CoC demonstrates a cancer program’s commitment to providing high-quality, multidisciplinary, patient-centered care and access to the full scope of cancer care services required to diagnose, treat, rehabilitate and support patients along their journey.

“We are proud to kick off the new year with CoC re-accreditation,” said Cancer Committee Chair Sean Cavanaugh, MD, chief of radiation oncology. “This accomplishment is testament to the collective leadership and hard work put forth by our physicians, clinicians and many other team members who put their heart and soul into achieving national standards of care for our patients as well as our community.”

CoC-accredited cancer programs offer cancer patients: comprehensive care; a multidisciplinary, team approach; treatment planning based on evidence-based national treatment guidelines; clinical trials and new treatment options; follow-up care including a survivorship care plan; and more.

In addition to the Commission on Cancer, CTCA Atlanta is accredited and recognized by several renowned professional health care organizations that assess and monitor the quality of patient care, including The Joint Commission, Quality Oncology Practice Initiative (QOPI) and National Accreditation Program For Breast Cancers (NAPBC).

Board certified medical oncologists Bamidele Adesunloye, MD, MS, FACP and Hima Bindu Lingam, MD have joined an experienced roster of nearly 200 physicians at Cancer Treatment Centers of America® (CTCA) in metro Atlanta.  Specifically, Drs. Adesunloye and Lingam will serve the specialty hospital’s Genitourinary Cancer Center and Thoracic Cancer Center, respectively.

Prior to joining CTCA®, Dr. Adesunloye served as the division director of oncology services and director of clinical research at Indiana University Health in Lafayette, Ind. He was also the principal investigator of multiple clinical trials and has co-authored journal articles and book chapters in the area of genitourinary malignancies. Board certified in medical oncology, hematology and internal medicine, Dr. Adesunloye is a member of the National Cancer Institute (NCI)’s Central Institutional Review Board, which provides oversight to NCI-funded clinical trials.

Dr. Lingam, board certified in medical oncology and hematology, has practiced in a variety of healthcare settings since 2007. Prior to CTCA Atlanta, she built and directed the oncology clinical trials program at Kaiser Permanente Georgia as part of the Kaiser Permanente National Cancer Institute Community Oncology Research Program (NCORP). Dr. Lingam is dedicated to deepening her impact in the oncology space with special interests in research, community outreach and policymaking.

“The additions of Dr. Adesunloye and Dr. Lingam not only expand our medical oncology team but also our disease-specific expertise,” said Dr. Alan Yahanda, CTCA Atlanta chief of staff.  “We look forward to their contribution to our clinical culture as we serve more cancer patients in the new year, including those from our home state of Georgia.”

Dr. Adesunloye received a medical degree at the University of Ilorin in Nigeria. He completed fellowship training in hematology and oncology at the National Cancer Institute, part of the National Institutes of Health. Dr. Adesunloye also completed a residency in internal medicine and received a Master of Science in clinical research at the Morehouse School of Medicine in Atlanta.

Dr. Lingam received a bachelor’s degree in biochemistry from Brown University in Providence, R.I. She earned her medical degree from Meharry Medical College in Nashville, Tenn., and completed an internal medicine residency at Tufts Medical Center in Boston. She also completed a fellowship in hematology/oncology at Baylor College of Medicine in Houston. Dr. Lingam is an active member of several professional organizations including the American Medical Association, American Society of Clinical Oncology, American Association of Physicians of Indian Origin and Alpha Omega Alpha Honor Medical Society.